CTRI/2020/03/023697尚未招募2 期
A Randomized, Open-Label, Active Controlled, Parallel-Group Clinical Study to Compare the Safety and Efficacy of Itrifal Shahtra and Marham Hina with PUVAsol and Petroleum Jelly in the Management of Taqashshur al-Jild (Psoriasis)
ational Research Institute of Unani Medicine for Skin Disorders0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1-Patients of any sex in the age group between 18 and 65 years
- •2-Patients with clinically diagnosed Taqashshur al-Jild (Psoriasis) of plaque-type
- •3-Psoriasis area severity index (PASI) of >=10%
排除标准
- •1-Patients aged < 18 years or > 65 years
- •2-Pregnant and lactating mothers
- •3-Significant pulmonary/cardiovascular/hepato-renal dysfunction
- •4-Known cases of Immunocompromised states (HIV/ AIDS, etc.)
- •5-Patient not willing to attend treatment schedule regularly
研究者
相似试验
已完成
3 期
A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine.CTRI/2010/091/000071GlaxoSmithKline500
进行中（未招募）
1 期
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes MellitusMedDRA version: 12.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-015386-30-GBSmithKline Beecham Corporation (doing business as GlaxoSmithKline)
进行中（未招募）
不适用
A research study comparing the long term safety (48 weeks) of the investigational drug SUN101 (glycopyrrolate) given by a nebulizer, with tiotropium bromide inhalation powder (Spiriva®) in patients with Chronic Obstructive Pulmonary Disease (COPD).MedDRA version: 17.1Level: PTClassification code 10009033Term: Chronic obstructive pulmonary diseaseSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersEUCTR2013-002696-18-CZSunovion Respiratory Development Inc.1,050
进行中（未招募）
1 期
A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine as Compared with the Combination of Insulin Glargine and Preprandial Lispro Insulin in Subjects With Type 2 Diabetes MellitusMedDRA version: 12.0 Level: LLT Classification code 10045242 Term: Type II diabetes mellitusType 2 Diabetes MellitusEUCTR2009-015386-30-FRSmithKline Beecham Corporation (doing business as GlaxoSmithKline)
进行中（未招募）
不适用
A research study comparing the long term safety (48 weeks) of the investigational drug SUN101 (glycopyrrolate) given by a nebulizer, with tiotropium bromide inhalation powder (Spiriva®) in patients with Chronic Obstructive Pulmonary Disease (COPD).EUCTR2013-002696-18-HUSunovion Respiratory Development Inc.1,050